In this context, recent studies have associated the LDLR polymorphisms (c.*52 A/G, c.*504 A/G, and c.*773 A/G) with low levels of plasma lipids and the risk of developing familial hypercholesterolemia [9,10,11,23]. This evidence concerns the gene LDLR and familial hypercholesterolemia.